Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > EXLSX > Summary

Manning & Napier Life Sciences
(EXLSX)

10.61USD   Up0.13 (1.24%)   
On Feb 10
 Manning & Napier Life Sciences Delayed quote data 
Net Asset Value: 10.61
Trade Time:Feb 10
Change:Up0.13 (1.24%)
Prev Close:10.48
YTD Return*:43.06%
Net Assets*:258.36M
Yield*:N/A
* As of 30-Nov-09		[Chart]
3m  6m  1y  2y  5y  max 
Add EXLSX to Portfolio   Download Data

HEADLINES

 
•Life Science Stocks: A Growing Market in 2010 - BusinessWeek  - Mon, Dec 28
» More Headlines for EXLSX...

FUND BASICS

30-Nov-09
Total Assets:258.36M
Category:N/A
Morningstar Overall Rating:3 stars
» Fund Profile» Holdings

PERFORMANCE & RISK

30-Nov-09
YTD Return:43.06%
5y Avg Return:5.39%
Rank in Category (ytd):3
% Rank in Category (ytd):N/A
Beta (3y):1.05
Morningstar Risk Rating:Above average
» Performance Details» Risk Details

FUND SUMMARY

 
The investment seeks long-term growth. The fund invests at least 80% of assets in securities of companies involved in the life sciences industry. It may invest in U.S. and foreign stocks, including American Depository Receipts (ADRs) and other U.S. dollar denominated securities of foreign issuers. The fund is nondiversified.
» Fund Profile